Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8332206 | International Journal of Biological Macromolecules | 2015 | 11 Pages |
Abstract
The most active sulfated fucan combined with acyclovir was particularly effective, so may be particularly suitable for further experimental testing in order to develop treatment protocols for AD patients, with the aim of slowing or stopping disease progression.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Matthew Wozniak, Tracey Bell, Ádám Dénes, Ruth Falshaw, Ruth Itzhaki,